These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 8444849)
1. In vitro and in vivo characterization of a neutral boron-containing thrombin inhibitor. Tapparelli C; Metternich R; Ehrhardt C; Zurini M; Claeson G; Scully MF; Stone SR J Biol Chem; 1993 Mar; 268(7):4734-41. PubMed ID: 8444849 [TBL] [Abstract][Full Text] [Related]
2. Benzyloxycarbonyl-D-Phe-Pro-methoxypropylboroglycine: a novel inhibitor of thrombin with high selectivity containing a neutral side chain at the P1 position. Claeson G; Philipp M; Agner E; Scully MF; Metternich R; Kakkar VV; DeSoyza T; Niu LH Biochem J; 1993 Mar; 290 ( Pt 2)(Pt 2):309-12. PubMed ID: 8452516 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and characterisation of novel thrombin inhibitors based on 4-amidinophenylalanine. Reers M; Koschinsky R; Dickneite G; Hoffmann D; Czech J; Stüber W J Enzyme Inhib; 1995; 9(1):61-72. PubMed ID: 8568567 [TBL] [Abstract][Full Text] [Related]
4. The selective inhibition of thrombin by peptides of boroarginine. Kettner C; Mersinger L; Knabb R J Biol Chem; 1990 Oct; 265(30):18289-97. PubMed ID: 2211702 [TBL] [Abstract][Full Text] [Related]
5. Modulating platelet function with selective thrombin inhibitors. Verstraete M Haemostasis; 1996 Oct; 26 Suppl 4():70-7. PubMed ID: 8979113 [TBL] [Abstract][Full Text] [Related]
6. In vitro antiplatelet profile of FR171113, a novel non-peptide thrombin receptor antagonist. Kato Y; Kita Y; Nishio M; Hirasawa Y; Ito K; Yamanaka T; Motoyama Y; Seki J Eur J Pharmacol; 1999 Nov; 384(2-3):197-202. PubMed ID: 10611442 [TBL] [Abstract][Full Text] [Related]
7. Selection of S18326 as a new potent and selective boronic acid direct thrombin inhibitor. Rupin A; Mennecier P; Lila C; de Nanteuil G; Verbeuren TJ Thromb Haemost; 1997 Oct; 78(4):1221-7. PubMed ID: 9364988 [TBL] [Abstract][Full Text] [Related]
8. Characterization of a class of peptide boronates with neutral P1 side chains as highly selective inhibitors of thrombin. Deadman JJ; Elgendy S; Goodwin CA; Green D; Baban JA; Patel G; Skordalakes E; Chino N; Claeson G; Kakkar VV J Med Chem; 1995 Apr; 38(9):1511-22. PubMed ID: 7739010 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of selective boron-containing thrombin inhibitors. Wienand A; Ehrhardt C; Metternich R; Tapparelli C Bioorg Med Chem; 1999 Jul; 7(7):1295-307. PubMed ID: 10465405 [TBL] [Abstract][Full Text] [Related]
10. Molecular design and characterization of an alpha-thrombin inhibitor containing a novel P1 moiety. Malikayil JA; Burkhart JP; Schreuder HA; Broersma RJ; Tardif C; Kutcher LW; Mehdi S; Schatzman GL; Neises B; Peet NP Biochemistry; 1997 Feb; 36(5):1034-40. PubMed ID: 9033393 [TBL] [Abstract][Full Text] [Related]
11. Bifunctional peptide boronate inhibitors of thrombin: crystallographic analysis of inhibition enhanced by linkage to an exosite 1 binding peptide. Skordalakes E; Elgendy S; Goodwin CA; Green D; Scully MF; Kakkar VV; Freyssinet JM; Dodson G; Deadman JJ Biochemistry; 1998 Oct; 37(41):14420-7. PubMed ID: 9772168 [TBL] [Abstract][Full Text] [Related]
12. Comparative anticoagulant effects of various thrombin inhibitors, as determined in the ecarin clotting time method. Callas DD; Fareed J Thromb Res; 1996 Sep; 83(6):463-8. PubMed ID: 8885140 [No Abstract] [Full Text] [Related]
13. Inhibition by Argatroban, a specific thrombin inhibitor, of platelet activation by fibrin clot-associated thrombin. Lunven C; Gauffeny C; Lecoffre C; O'Brien DP; Roome NO; Berry CN Thromb Haemost; 1996 Jan; 75(1):154-60. PubMed ID: 8713795 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the structures of the cyclotheonamide A complexes of human alpha-thrombin and bovine beta-trypsin. Ganesh V; Lee AY; Clardy J; Tulinsky A Protein Sci; 1996 May; 5(5):825-35. PubMed ID: 8732754 [TBL] [Abstract][Full Text] [Related]
15. Thrombin inhibitors and anti-coagulants on thrombin-induced embolisation in rabbit cranial vasculature. Liu JT; Paul W; Emerson M; Cicala C; Page CP Eur J Pharmacol; 1994 Oct; 264(2):183-90. PubMed ID: 7851481 [TBL] [Abstract][Full Text] [Related]
16. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design. Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442 [TBL] [Abstract][Full Text] [Related]
19. Refined 2.3 A X-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors NAPAP, 4-TAPAP and MQPA. A starting point for improving antithrombotics. Brandstetter H; Turk D; Hoeffken HW; Grosse D; Stürzebecher J; Martin PD; Edwards BF; Bode W J Mol Biol; 1992 Aug; 226(4):1085-99. PubMed ID: 1518046 [TBL] [Abstract][Full Text] [Related]
20. New tripeptidic thrombin inhibitors. Influence of P2 and P3 residues on activity and selectivity. De Nanteuil G; Gloanec P; Lila C; Portevin B; Boudon A; Rupin A; Verbeuren TJ Bioorg Med Chem; 1995 Aug; 3(8):1019-24. PubMed ID: 7582976 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]